Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

CGC-11047 studied in patients with AMD

Nov. 10, 2006

Lux licenses ciclosporin-eluting silicone matrix ocular implant from NIH

Nov. 9, 2006

MacuSight's proprietary sirolimus formulation begins phase I study in wet AMD

Nov. 6, 2006

TG-100801 for ocular diseases studied in phase I

Nov. 3, 2006

Recent PhotoBioChem patent describes new porphyrin derivatives for AMD

Oct. 30, 2006

Bayer and Regeneron to collaborate on VEGF Trap-Eye

Oct. 23, 2006

BVT-28949 begins phase II study for glaucoma

Oct. 18, 2006

Phase III trial of NOVA-22007 in vernal keratoconjunctivitis completes enrollment

Oct. 9, 2006

Santhera to develop SNT-MC17 for Leber's hereditary optic neuropathy

Oct. 2, 2006

L-90268: a novel prostanoid EP4 receptor agonist with ocular hypotensive activity

Sep. 29, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...